IL25 and gastric cancer: The results revealed that the density of IL-25+IT cells (HR = 0.5; 95% CI, 0.3–0.9; p = 0.024), tumor location (HR = 0.5; 95% CI, 0.3–0.9; p = 0.016) and TNM stage (HR = 3.7; 95% CI, 1.9–7.1; p < 0.001) were independent prognostic factors for OS in patients with GC.